KEENSIGHT CAPITAL
KEENSIGHT CAPITAL is a Series C+ and buyout fund in Europe writing $10M–$800M checks into Healthcare and technology.
- Stages
- Series C+, buyout
- Sectors
- Healthcare, technology
- Check size
- $10M–$800M
- Invests in
- Europe
- Actively investing
- Yes
- Founded
- 1998
- Assets under management
- >€8B
Thesis
Keensight Capital is a European private equity firm founded in 1998, specializing in growth buyout strategies within the technology and healthcare sectors. They focus on profitable companies with revenues between €10 million and €400 million, aiming to finance organic growth, facilitate acquisitions, or provide liquidity. Keensight operates as both a minority and majority partner, offering capital, strategic guidance, and operational support. The firm primarily invests across Europe and has a global presence with offices in Paris, London, Boston, and Singapore. As of December 31, 2025, their AUM exceeded €8 billion. They provide investment tickets ranging from €10 million to €800 million. Keensight emphasizes ESG principles and fosters collaboration through its 'Keensight Connect' platform.
Common questions
Does KEENSIGHT CAPITAL invest at the Series C+ stage?
Yes. KEENSIGHT CAPITAL lists Series C+ and buyout among the stages it invests in.
What check size does KEENSIGHT CAPITAL write?
KEENSIGHT CAPITAL writes $10M–$800M checks.
Where does KEENSIGHT CAPITAL invest?
KEENSIGHT CAPITAL invests in Europe.